Argitalpenak (37) Ana Chopitea Ortega argitalpenak

2023

  1. Liver Resection and Transplantation Following Yttrium-90 Radioembolization for Primary Malignant Liver Tumors: A 15-Year Single-Center Experience

    Cancers, Vol. 15, Núm. 3

  2. Therapeutic drug monitoring of neoadjuvant mFOLFIRINOX in resected pancreatic ductal adenocarcinoma

    Pancreatology, Vol. 23, Núm. 4, pp. 411-419

2022

  1. Impact on the Nutritional Status and Inflammation of Patients with Cancer Hospitalized after the SARS-CoV-2 Lockdown

    Nutrients, Vol. 14, Núm. 13

2021

  1. Feasibility and patency of echoendoscopic anastomoses with lumen apposing metal stents depending on the gastrointestinal segment involved

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Successful desensitization to oxaliplatin after a single initial dose of omalizumab in a patient with elevated IgE levels

    Journal of Investigational Allergology and Clinical Immunology

2019

  1. Neoadjuvant therapy for locally advanced gastric cancer patients. A population pharmacodynamic modeling

    PLoS ONE, Vol. 14, Núm. 5

  2. Use of machine-learning algorithms in intensified preoperative therapy of pancreatic cancer to predict individual risk of relapse

    Cancers, Vol. 11, Núm. 5

2018

  1. A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasis 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis

    Journal for ImmunoTherapy of Cancer, Vol. 6, Núm. 1

  2. Adjuvant therapy for colon cancer: Genes, genes. . . And the patient in the center

    Clinical Cancer Research, Vol. 24, Núm. 16, pp. 3787-3789

  3. Intensified neoadjuvant multimodal approach in synchronous liver metastases from gastric cancer: a single institutional experience

    Clinical and Translational Oncology, Vol. 20, Núm. 5, pp. 658-665

  4. Segmental Pneumonitis after Radioembolization

    Journal of Vascular and Interventional Radiology

2017

  1. Mid-term oncologic outcome of a novel approach for locally advanced colon cancer with neoadjuvant chemotherapy and surgery

    Clinical and Translational Oncology, Vol. 19, Núm. 3, pp. 379-385

2016

  1. Role of histological regression grade after two neoadjuvant approaches with or without radiotherapy in locally advanced gastric cancer

    British Journal of Cancer, Vol. 115, Núm. 6, pp. 655-663

2015

  1. Development of the National Kidney Transplantation Program in Uruguay

    Transplantation Proceedings, Vol. 47, Núm. 8, pp. 2336-2339

  2. Long-term oncologic results in cancer of the rectum treated by preoperative chemoradiotherapy and surgery: An analysis of 500 cases

    Revista Espanola de Enfermedades Digestivas, Vol. 107, Núm. 6, pp. 340-346

  3. Radioembolization of hepatocellular carcinoma activates liver regeneration, induces inflammation and endothelial stress and activates coagulation

    Liver International, Vol. 35, Núm. 5, pp. 1590-1596

2014

  1. Analysis of surgical complications of primary tumor resection after neoadjuvant treatment in stage IV colon cancer

    Journal of Gastrointestinal Oncology, Vol. 5, Núm. 2, pp. 148-153

2013

  1. Preliminary outcome of a treatment strategy based on perioperative chemotherapy and surgery in patients with locally advanced colon cancer

    Colorectal Disease, Vol. 15, Núm. 5, pp. 552-557

  2. Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy

    Diseases of the Colon and Rectum, Vol. 56, Núm. 4, pp. 416-421

  3. Prognostic factors and prevention of radioembolization-induced liver disease

    Hepatology, Vol. 57, Núm. 3, pp. 1078-1087